SG10202005089XA - Mutants of the bacteriophage lambda integrase - Google Patents

Mutants of the bacteriophage lambda integrase

Info

Publication number
SG10202005089XA
SG10202005089XA SG10202005089XA SG10202005089XA SG10202005089XA SG 10202005089X A SG10202005089X A SG 10202005089XA SG 10202005089X A SG10202005089X A SG 10202005089XA SG 10202005089X A SG10202005089X A SG 10202005089XA SG 10202005089X A SG10202005089X A SG 10202005089XA
Authority
SG
Singapore
Prior art keywords
mutants
bacteriophage lambda
lambda integrase
integrase
bacteriophage
Prior art date
Application number
SG10202005089XA
Inventor
Farid Ghadessy
Jia Wei Siau
Peter Droge
Harshyaa Makhija
Chandra Shree Harsha Vijaya
Sabrina Peter
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Publication of SG10202005089XA publication Critical patent/SG10202005089XA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases RNAses, DNAses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00Bacteriophages
    • C12N2795/00011Details
    • C12N2795/10011Details dsDNA Bacteriophages
    • C12N2795/10311Siphoviridae
    • C12N2795/10322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
SG10202005089XA 2014-08-08 2015-08-11 Mutants of the bacteriophage lambda integrase SG10202005089XA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1414130.3A GB201414130D0 (en) 2014-08-08 2014-08-08 Mutants of the bacteriophage lambda integrase

Publications (1)

Publication Number Publication Date
SG10202005089XA true SG10202005089XA (en) 2020-07-29

Family

ID=51629549

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201700955SA SG11201700955SA (en) 2014-08-08 2015-08-11 Mutants of the bacteriophage lambda integrase
SG10202005089XA SG10202005089XA (en) 2014-08-08 2015-08-11 Mutants of the bacteriophage lambda integrase

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201700955SA SG11201700955SA (en) 2014-08-08 2015-08-11 Mutants of the bacteriophage lambda integrase

Country Status (7)

Country Link
US (2) US10344301B2 (en)
EP (1) EP3177717A4 (en)
JP (1) JP6616822B2 (en)
CN (1) CN108064279B (en)
GB (1) GB201414130D0 (en)
SG (2) SG11201700955SA (en)
WO (1) WO2016022075A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201414130D0 (en) * 2014-08-08 2014-09-24 Agency Science Tech & Res Mutants of the bacteriophage lambda integrase
GB201603577D0 (en) * 2016-03-01 2016-04-13 Oxford Genetics Ltd Promoter
US11078493B2 (en) 2016-06-21 2021-08-03 Nanyang Technological University Site-specific DNA recombination
CN110914414A (en) 2017-06-14 2020-03-24 德累斯顿工业大学 Methods and means for genetically altering genomes using designed DNA recombinases
AU2020321901A1 (en) * 2019-07-29 2022-02-24 The Trustees Of Indiana University Materials and methods for treating Friedreich's Ataxia
EP4065984A1 (en) 2019-11-25 2022-10-05 Larimar Therapeutics, Inc. Methods for quantifying frataxin activity
CA3176208A1 (en) 2020-04-30 2021-11-04 Joan David Bettoun Methods for treating myelin associated diseases and mitochondria associated diseases
CN117178056A (en) * 2021-03-12 2023-12-05 南洋理工大学 Method for producing seamless DNA vector
WO2023234866A1 (en) * 2022-05-31 2023-12-07 Nanyang Technological University Method for production of a eukaryotic host cell or cell line for lambda-integrase-mediated recombination

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2522166C (en) * 2001-05-30 2011-05-03 Chromos Molecular Systems, Inc. Lambda integrase mutein for use in recombination
JP4489424B2 (en) * 2001-05-30 2010-06-23 グラクソ グループ リミテッド Chromosome-based platform
CN103396904B (en) * 2008-11-11 2015-12-23 宝洁公司 Comprise composition and the method for serine protease variants
SG170652A1 (en) 2009-11-06 2011-05-30 Agency Science Tech & Res Muteins of the bacteriophage lambda integrases
GB201414130D0 (en) * 2014-08-08 2014-09-24 Agency Science Tech & Res Mutants of the bacteriophage lambda integrase

Also Published As

Publication number Publication date
CN108064279B (en) 2022-03-11
US20170327847A1 (en) 2017-11-16
US10344301B2 (en) 2019-07-09
CN108064279A (en) 2018-05-22
WO2016022075A1 (en) 2016-02-11
JP6616822B2 (en) 2019-12-04
JP2017525355A (en) 2017-09-07
EP3177717A4 (en) 2017-12-27
EP3177717A1 (en) 2017-06-14
US20200063165A1 (en) 2020-02-27
GB201414130D0 (en) 2014-09-24
US11414681B2 (en) 2022-08-16
SG11201700955SA (en) 2017-03-30

Similar Documents

Publication Publication Date Title
HK1232140A1 (en) Micro-organoids, and methods of making and using the same
HK1232147A1 (en) Cenicriviroc for the treatment of fibrosis
SG11201700955SA (en) Mutants of the bacteriophage lambda integrase
IL254476A0 (en) Heterocyclylmethyl-thienouracile as antagonists of the adenosine-a2b-receptor
HK1244485A1 (en) Combinations for the treatment of neuroblastoma
HRP20200171T1 (en) Modifying bacteriophage
LT3256486T (en) Griffithsin mutants
HK1257272A1 (en) Means for the treatment of hiv
ZA201702248B (en) Recombinase mutants
GB201417808D0 (en) Modified bacteriophage
HK1247558A1 (en) Cenicriviroc for the treatment of fibrosis
GB201417805D0 (en) Modifield bacteriophage
HK1250381A1 (en) Detection of bacteria using bacteriophage
GB201417811D0 (en) Modifying bacteriophage
IL255819A (en) Improved processes for the preparation of sofosbuvir and intermediates thereof
IL253077A0 (en) Process and intermediates for the preparation of perampanel
ZA201608823B (en) Processes for the preparation of azd5363 and novel intermediate used therein
GB2544957B (en) Modifying bacteriophage
LT3440200T (en) Modified bacteriophage
GB201402924D0 (en) The theory of instantransmission